Companies / AVH

AVITA MEDICAL INC.

ASX:AVHPharmaceuticals, Biotechnology & Life Sciences
154.6M shares on issueASX (delayed) · as of 28 July 2026$1.31price · delayed$203.3Mmarket cap · indicative
B
Dilution grade

Options/rights overhang 136% of shares; 1 cash raise in 24 months

Cash runwayno data — not a quarterly (4C/5B) cash filer
Share-count growth (24m)0.0%no issuance filings since 2024
Raise cadence (24m)1 cash raise
Options & rights overhang135.9% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

AVITA MEDICAL INC.'s ordinary share count was 91M as of August 2025 (no earlier share-count series provided). The company reported no new Appendix 2A share-issuance filings since January 2024. It raised capital once in the 24-month window for total proceeds of A$22.7M, most recently in August 2025 for A$22.7M. Options and rights could convert into 210M new shares, equal to 135.9% of the current share count, with 0% in the money and the nearest expiry in December 2031. The company does not have a current quarterly cash report on record, so no quarterly cash balance or runway figure is disclosed. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
135.9%
Max option dilution
0.0%
ITM option dilution
1
Raises · last 12 months
—
Cash cover · not a quarterly filer

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 154.6M per ASX (delayed) (28 July 2026).
136.0M142.9M149.7MDec 24Sept 25July 26Cash raise · 12 Aug 2025

Cash runway

Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
12 July 20263G · unquotedCHESS DEPOSITARY INTERESTS85.7MAppendix 3G
12 July 20263G · unquotedAVH : CHESS DEPOSITARY INTERESTS 5:185.7MAppendix 3G
8 July 20263H · cancellationAVH : CHESS DEPOSITARY INTERESTS85.7MAppendix 3H
3 July 20263H · cancellationAVH : CHESS DEPOSITARY INTERESTS 5:185.7MAppendix 3H
11 June 20263G · unquotedCHESS DEPOSITARY INTERESTS85.7MAppendix 3G
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

1 cash raise in the last 24 months · 1 in the last 12 months

$22.7M
Capital raise
12 Aug 2025
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

135.9%
Total overhang · of current shares
0.0%
In the money · at current price
210.1M
Potential new shares
Dec 2031
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
3 June 2026Jan Stern ReedOther—16k—3Y notice
3 June 2026Robert McNamaraOther3k16k—3Y notice
3 June 2026Cary G. VanceOther3k——3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

14 July 2026AVITA to Announce Second Quarter 2026 Financial Results
14 July 2026Statement of CDIs on issue - AVH
12 July 2026Notification regarding unquoted securities - AVH
12 July 2026Notification regarding unquoted securities - AVH
8 July 2026Notification of cessation of securities - AVH
3 July 2026Notification of cessation of securities - AVH
18 June 2026AVITA Highlights first UK Clinical Experience with RECELL GO
11 June 2026Financial Report on Form 8-K Dated 5 June 2026
11 June 2026Change of Director's Interest Notice -SC JCC RM JSR MT CV JW
11 June 2026Notification regarding unquoted securities - AVH
11 June 2026Notification regarding unquoted securities - AVH
4 June 2026Statement of CDIs on issue - AVH
3 June 20262026 ASM Board Chair Script
3 June 2026Change of Director's Interest Notice - JW
3 June 2026Results of 2026 Annual Meeting of Stockholders
2 June 2026Change of Director's Interest Notice
2 June 2026Notification regarding unquoted securities - AVH
2 June 2026Notification of cessation of securities - AVH
17 May 2026AVITA AU Q1 Investor Briefing Presentation
17 May 2026AVITA Medical to Host Investor Webinar Briefing

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.